Brief: Translational Medicine - Drug Development Transformed? (Market Focus) from Piribo.com

Summary

Introduction

A paradigm shift is emerging in the pharmaceutical industry that will change drug discovery and development. The shift towards translational medicine will largely depend on the ability of technology vendors to offer solutions to both the cultural and technology issues surrounding translational research.

Scope

Geographic coverage includes the US, Canada and Western Europe

Builds on ongoing primary research with pharmaceutical companies, technology vendors, physicians, consumers and healthcare organizations

Highlights

Translational medicine is real and fueled by healthcare trends, such as consumerism and personalized care

Existing business models are called into question, driving translational medicine

Both cultural and technology barriers slow the progress of translational medicine

Reasons to Purchase

Identify and evaluate factors that will affect translational medicine in the pharmaceutical industry

Understand the market factors driving technology adoption by pharmaceutical companies

Align your strategy with developments in the pharmaceutical industry

Content

Catalyst
Summary
Methodology
Analysis
- Translational medicine is real and fueled by patient-centered care
- Defining translational medicine
- The pharmaceutical industry mirrors healthcare trends
- Existing business models are called into question, driving translational medicine
- A deepening research & development crisis is driving the adoption of alternative business models
- Demographic shifts will overburden existing health systems
- Threat by low-cost generic drugs is changing the industry's focus towards high value products
- Private and public industry initiatives indicate translational medicine is gaining momentum
- Both cultural and technology barriers slow the progress of translational medicine
- Translational medicine challenges the traditional culture of drug development
- Translational medicine requires a level of technology infrastructure that transcends the lab
- A lack of urgency by some companies will slow the overall adoption of translational medicine
- Data analytics will catalyze translational medicine and connect it to patient-centered care
Actions
- Present technology for translational medicine as part of an existing and familiar solution
- Position technology as a partner in drug discovery and development
- Demystify cultural and technology challenges by educating end-users early
Appendix
- Definitions
- Abbreviations
- External methodology
- Further reading
- Datamonitor Technology Consultancy
- Ask the analyst
List of Figures
- Figure 1: Translational medicine vs. traditional drug development
- Figure 2: as healthcare moves towards patient-centered care, the pharmaceutical industry takes a parallel direction through translational medicine
- Figure 3: despite increased spending on R&D, the pharmaceutical industry is facing a deep productivity crisis
- Figure 4: An aging population worldwide will put pressure on the pharmaceutical industry and overburden healthcare markets overall
- Figure 5: Fiercely autonomous silos of R&D research and clinical development characterize most pharmaceutical companies
- Figure 6: Technology must move towards the core of drug discovery and development

Research (R&D)

Translational Medicine - Drug Development Transformed? (Market Focus)

Drug Development Transformed? (Market Focus)